Thomas Manley

4.4k total citations
47 papers, 2.7k citations indexed

About

Thomas Manley is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Manley has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Immunology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Manley's work include Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Thomas Manley is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Thomas Manley collaborates with scholars based in United States, France and United Kingdom. Thomas Manley's co-authors include Jerome Ritz, Michael A. Caligiuri, Herbert Levine, Michael J. Robertson, Kendall A. Smith, Christine P. Donahue, M. J. Robertson, H Levine, Stanley R. Riddell and Matthias Wölfl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Thomas Manley

46 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Manley United States	21	1.7k	845	400	301	300	47	2.7k
Joannis Mytilineos Germany	30	1.5k 0.8×	416 0.5×	471 1.2×	371 1.2×	657 2.2×	120	2.9k
Pascale Paul France	41	3.9k 2.2×	521 0.6×	334 0.8×	627 2.1×	268 0.9×	99	5.0k
Conleth Feighery Ireland	32	1.3k 0.8×	347 0.4×	751 1.9×	390 1.3×	216 0.7×	125	3.7k
Natacha Patey France	21	1.5k 0.8×	333 0.4×	918 2.3×	425 1.4×	114 0.4×	38	3.2k
Adriana I. Colovai United States	29	1.9k 1.1×	324 0.4×	224 0.6×	334 1.1×	259 0.9×	73	3.1k
Paul A. Blair United Kingdom	11	1.9k 1.1×	297 0.4×	548 1.4×	471 1.6×	104 0.3×	14	2.9k
Iwao Sekigawa Japan	29	1.1k 0.6×	323 0.4×	296 0.7×	509 1.7×	155 0.5×	112	2.2k
David Senitzer United States	28	1.1k 0.6×	295 0.3×	433 1.1×	254 0.8×	647 2.2×	115	2.3k
John Prehn United States	23	1.6k 0.9×	464 0.5×	334 0.8×	476 1.6×	190 0.6×	41	2.6k
Massimo Fiorilli Italy	28	1.1k 0.6×	284 0.3×	584 1.5×	468 1.6×	204 0.7×	118	2.5k

Countries citing papers authored by Thomas Manley

Since Specialization

Citations

This map shows the geographic impact of Thomas Manley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Manley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Manley more than expected).

Fields of papers citing papers by Thomas Manley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Manley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Manley. The network helps show where Thomas Manley may publish in the future.

Co-authorship network of co-authors of Thomas Manley

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Manley. A scholar is included among the top collaborators of Thomas Manley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Manley. Thomas Manley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manley, Thomas, Starlynn Clarke, Manpreet Kaur, et al.. (2025). A novel CD28 x Nectin-4 costimulatory bispecific antibody for advanced bladder cancer.. Journal of Clinical Oncology. 43(5_suppl). 810–810. 1 indexed citations

Li, Keyu, Liqin Liu, Daniel Santos, et al.. (2023). Abstract 2959: Novel CD38xCD3 bispecific IgM T cell engager, IGM-2644, potently kills multiple myeloma cells though complement and T cell dependent mechanisms. Cancer Research. 83(7_Supplement). 2959–2959. 1 indexed citations

Logronio, Kathryn, Miho Oyasu, Genevive Hernandez, et al.. (2023). Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma. Hematological Oncology. 41(S2). 552–553. 1 indexed citations

Nastoupil, Loretta J., Lihua E. Budde, Won Seog Kim, et al.. (2022). Abstract CT125: A phase 1/2 randomized study of IGM-2323 in relapsed/refractory non-Hodgkin lymphomas. Cancer Research. 82(12_Supplement). CT125–CT125. 1 indexed citations

Ramchandren, Radhakrishnan, Ranjana H. Advani, Stephen M. Ansell, et al.. (2019). Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma. Clinical Cancer Research. 25(6). 1718–1726. 30 indexed citations

Kelly, Kara M., Stephen Daw, Christine Mauz‐Körholz, et al.. (2019). RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. Hematological Oncology. 37(S2). 56–57. 3 indexed citations

Sprague, Stuart M., Ezequiel Bellorín-Font, Vanda Jorgetti, et al.. (2015). Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. American Journal of Kidney Diseases. 67(4). 559–566. 211 indexed citations

Yasenchak, Christopher A., Ahmad Halwani, Ranjana H. Advani, et al.. (2015). Brentuximab Vedotin with RCHOP As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL): Results from an Ongoing Phase 2 Study. Blood. 126(23). 814–814. 7 indexed citations

Jaspan, Heather B., Adam Brothers, Angela Campbell, et al.. (2010). MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLER. The Pediatric Infectious Disease Journal. 29(4). 379–381. 60 indexed citations

10.

Tykodi, Scott S., Brenda M. Sandmaier, Michael B. Maris, et al.. (2007). Ex vivo isolation of RCC-reactive CD8⁺ CTL clones from HLA-identical allogeneic donor T cell lines stimulated by CD80-transfected tumor cells. Journal of Clinical Oncology. 25(18_suppl). 15625–15625. 1 indexed citations

11.

Manley, Thomas, et al.. (2004). Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood. 104(4). 1075–1082. 92 indexed citations

12.

Wu, Jennifer D., N. Jan Chalupny, Thomas Manley, et al.. (2003). Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein. The Journal of Immunology. 170(8). 4196–4200. 117 indexed citations

13.

Mutimer, Helen P., Yoshiki Akatsuka, Thomas Manley, et al.. (2002). Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus‐Specific Cytotoxic T Cell Response. The Journal of Infectious Diseases. 186(5). 701–705. 35 indexed citations

14.

Awaya, Norihiro, Gabriela M. Baerlocher, Thomas Manley, et al.. (2002). Telomere shortening in hematopoietic stem cell transplantation: A potential mechanism for late graft failure?. Biology of Blood and Marrow Transplantation. 8(11). 597–600. 39 indexed citations

15.

Robertson, Michael J., Thomas Manley, Gabriella Pichert, et al.. (1995). Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells. Leukemia & lymphoma. 17(1-2). 51–61. 88 indexed citations

16.

Baume, D, Michael J. Robertson, Herbert Levine, et al.. (1992). Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. European Journal of Immunology. 22(1). 1–6. 110 indexed citations

17.

Robertson, M. J., RJ Soiffer, S F Wolf, et al.. (1992). Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.. The Journal of Experimental Medicine. 175(3). 779–788. 315 indexed citations

18.

Baume, D, Michael A. Caligiuri, Thomas Manley, John Daley, & Jerome Ritz. (1990). Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cellular Immunology. 131(2). 352–365. 62 indexed citations

19.

Robertson, Michael J., Michael A. Caligiuri, Thomas Manley, H Levine, & Jerome Ritz. (1990). Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.. The Journal of Immunology. 145(10). 3194–3201. 195 indexed citations

20.

Caligiuri, Michael A., et al.. (1990). Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.. The Journal of Experimental Medicine. 171(5). 1509–1526. 359 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact